Latigo Biotherapeutics, Inc. (LTGO)
NASDAQ · Manufacturing · Pharmaceutical preparations
$17.13−$0.6300 (−3.55%) on the dayAs of the close; data may be delayed.
LTGO price, last 12 months
Key stats
- Previous close
- $17.76
- Open
- $17.81
- Day range
- $17.00 – $18.26
- 52-week range
- $17.00 – $25.93
- Volume
- 242.6K
- Avg volume (20 days)
- 326.4K
- Market cap
- $1.1B
Performance
1W−24.0%
1M−29.0%
3M—
6M—
YTD—
1Y—
Technicals and fundamentals
About Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.1B